Kent Ertugrul was Interim Chairman of the Board and Chief Executive Officer (CEO) of Phorm Inc., a Delaware corporation.[1] He resigned from the Phorm Corporation board on 15 July 2015.[2] Phorm ceased trading on 14 April 2016, having burnt through £200 million of investors' capital.[3]
{{cite web}}
: CS1 maint: archived copy as title (link)